0000950170-24-046064.txt : 20240419 0000950170-24-046064.hdr.sgml : 20240419 20240419163902 ACCESSION NUMBER: 0000950170-24-046064 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240418 FILED AS OF DATE: 20240419 DATE AS OF CHANGE: 20240419 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cohen Paul CENTRAL INDEX KEY: 0001968794 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21392 FILM NUMBER: 24858328 MAIL ADDRESS: STREET 1: C/O AMARIN CORPORATION PLC STREET 2: 77 SIR JOHN ROGERSON'S QUAY, BLOCK C CITY: DUBLIN 2 STATE: L2 ZIP: D02 VK60 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMARIN CORP PLC\UK CENTRAL INDEX KEY: 0000897448 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C STREET 2: 77 SIR JOHN ROGERSON'S QUAY CITY: DUBLIN 2 STATE: L2 ZIP: D02 VK60 BUSINESS PHONE: 353 1 6699 020 MAIL ADDRESS: STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C STREET 2: 77 SIR JOHN ROGERSON'S QUAY CITY: DUBLIN 2 STATE: L2 ZIP: D02 VK60 FORMER COMPANY: FORMER CONFORMED NAME: AMARIN PHARMACEUTICALS PLC DATE OF NAME CHANGE: 20000201 FORMER COMPANY: FORMER CONFORMED NAME: ETHICAL HOLDINGS PLC DATE OF NAME CHANGE: 19930322 4 1 ownership.xml 4 X0508 4 2024-04-18 0000897448 AMARIN CORP PLC\UK AMRN 0001968794 Cohen Paul C/O AMARIN PHARMA, INC. 440 US HIGHWAY 22 BRIDGEWATER NJ 08807 true false false false false Stock Option (right to buy) 0.87 2024-04-18 4 A false 179795 0.00 A 2034-04-18 Ordinary Shares 179795 179795 D Restricted Stock Unit 0.00 2024-04-18 4 A false 50287 0.00 A Ordinary Shares 50287 50287 D On April 18, 2024, following the conclusion of the Issuer's annual general meeting of shareholders for 2024, the Reporting Person was granted an option to purchase 179,795 Ordinary Shares under the Plan and the Policy. The shares subject to this option shall vest and become exercisable over three years, with 33% to vest on the first anniversary of the grant date and the remaining balance vesting in equal quarterly installments over the subsequent two years on the first day of each April, July, October and January. The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. On April 18, 2024, following the conclusion of the Issuer's annual general meeting of shareholders for 2024, the Reporting Person was granted an award of 50,287 RSUs under the Plan and the Policy. These RSUs vest in three equal installments on each of April 18, 2025, April 18, 2026 and April 18, 2027. Not applicable. /s/ Tom Reilly, by power of attorney 2024-04-19